Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1Phase 2 1

Status

Completed 34Terminated 4Unknown 3Active not recruiting 3Recruiting 2Withdrawn 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 3Polycystic Ovary Syndrome 2

Interventions

Docetaxel 21Radiosurgery 19Radiotherapy 17Androgen Antagonists 14Leuprolide 11Goserelin 11bicalutamide 9enzalutamide 8Surveys and Questionnaires 8Prednisone 8Brachytherapy 8Blood Specimen Collection 8Abiraterone Acetate 8acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 7Radiotherapy, Intensity-Modulated 7Multiparametric Magnetic Resonance Imaging 7Gonadotropin-Releasing Hormone 7Triptorelin Pamoate 6pembrolizumab 4cabazitaxel 4abiraterone 4Standard of Care 4Positron Emission Tomography Computed Tomography 4Metformin 4Heavy Ion Radiotherapy 4Exercise 4Estramustine 4luprolide acetate gel depot 3darolutamide 3Watchful Waiting 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Prostatic Neoplasms × Flutamide × Clear all
NCT04248621 2021-07-29

Androgen Deprivation Therapy on Bone Mineral Density Change in Prostate Cancer Patients

Wonju Severance Christian Hospital

Phase 4 Unknown
164 enrolled
Genitourinary

Prostatic Neoplasms

NCT02742675 2020-07-07

Androgen Deprivation Therapy or Androgen Deprivation Therapy Plus Definitive Treatment (Radiation or Surgery)

Fudan University

Phase 2 Unknown
200 enrolled
Genitourinary

Prostatic Neoplasms

NCT00003734 2016-07-21

Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer

National Cancer Institute (NCI)

Phase 3 Unknown
276 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡